Neglected Tropical Disease Treatment Market Outlook Assessing Future Opportunities And Growth Prospects
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Neglected Tropical Disease Treatment Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The market for treating neglected tropical diseases has experienced robust growth recently. Projections indicate it will expand from $3.57 billion in 2025 to $3.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. This historical expansion is attributable to factors such as persistent disease prevalence in tropical areas, backing from worldwide health organizations, the broadening of donor-supported treatment initiatives, the accessibility of generic medicines, and intensified public health awareness campaigns.
The neglected tropical disease treatment market is projected to experience robust expansion over the coming years, with its size expected to reach $4.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be attributed to several factors, including increased investments in eradication programs, the rising adoption of integrated disease management approaches, the expansion of novel antiparasitic drug development, the proliferation of public-private partnerships, and a heightened focus on improving healthcare access in remote regions. Significant trends during the forecast period are set to include the wider deployment of combination drug therapies, an increasing emphasis on early disease detection programs, the growing utilization of mass drug administration strategies, the broadening of community-based treatment models, and an enhanced focus on ensuring treatment accessibility.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp
Which Significant Factors Are Encouraging Growth In The Neglected Tropical Disease Treatment Market?
An increase in infectious disease cases is projected to propel the expansion of the neglected tropical disease treatment market in the future. These conditions are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The growing incidence of infectious diseases stems from more frequent travel, enabling pathogens to quickly disseminate across different regions. Treatment for neglected tropical diseases supports the fight against infectious diseases by offering specific therapies designed to manage and eradicate their proliferation. Such treatments enhance public health, particularly for susceptible populations, by diminishing the impact of diseases and averting lasting impairments. For example, data from the UK Health Security Agency, a UK-based government body, indicated in February 2024 that tuberculosis occurrences in England escalated to 4,850 in 2023, representing a 10.7% jump from 4,380 cases in 2022. Consequently, the increased occurrence of infectious diseases is fueling the development of the neglected tropical disease treatment market.
How Are Different Segment Groups Identified Within The Neglected Tropical Disease Treatment Market?
The neglected tropical disease treatment market covered in this report is segmented –
1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class
2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides
2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins
3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides
4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments
Which Trends Are Shaping The Neglected Tropical Disease Treatment Market Landscape?
Leading firms within the negative pressure wound therapy (NPWT) sector are actively developing innovative portable and disposable NPWT devices to solidify their market standing. These compact, single-use medical instruments apply controlled suction to wounds, facilitating healing by extracting surplus fluids and fostering ideal conditions for tissue restoration, all while providing convenient mobility and removing the necessity for cumbersome, conventional setups. For example, Advanced Oxygen Therapy Inc., a US-based medical equipment manufacturer, introduced its NEXA Negative Pressure Wound Therapy (NPWT) system in June 2023. The NEXA NPWT system provides a distinctive and adaptable platform, merging the straightforwardness of disposable NPWT with the robust performance characteristics of conventional durable NPWT technology. This portable, quiet, and economical system is designed to deliver enhanced wound care efficacy at a reduced expense. AOTI’s NEXA and Topical Wound Oxygen (TWO2) therapy uniquely integrates higher-pressure oxygen delivery with non-contact cyclical compression and humidity, positioning it as a beneficial choice for the management and healing of chronic wounds.
Who Are The Key Market Participants In The Neglected Tropical Disease Treatment Market?
Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen
Access The Complete Neglected Tropical Disease Treatment Market Report:
Which Region Accounts For The Highest Share Of The Neglected Tropical Disease Treatment Market?
Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Neglected Tropical Disease Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp
Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2026, By The Business Research Company
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2026
Pain Management Devices And Therapies Global Market Report 2026
Defibrillator Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
